Imaging brain cholinergic activity with positron emission tomography: its role in the evaluation of cholinergic treatments in Alzheimer's dementia (Q32077087)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Imaging brain cholinergic activity with positron emission tomography: its role in the evaluation of cholinergic treatments in Alzheimer's dementia	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

1 reference

Europe PubMed Central

Imaging brain cholinergic activity with positron emission tomography: its role in the evaluation of cholinergic treatments in Alzheimer's dementia (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

positron emission tomography

1 reference

based on heuristic

inferred from title

author name string

Volkow ND

1

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Ding YS

2

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Fowler JS

3

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Gatley SJ

4

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

language of work or name

0 references

publication date

1 February 2001

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

211-220

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Potential for imaging cerebral amyloid deposits using 123I-labelled serum amyloid P component and SPET.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Synthesis and evaluation of 6-[11C]methoxy-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-1,2- benzisoxazole as an in vivo radioligand for acetylcholinesterase.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Muscarinic cholinergic receptor measurements with [18F]FP-TZTP: control and competition studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

2-[18F]F-A-85380: a PET radioligand for alpha4beta2 nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

A comparison of the binding of nicotine and nornicotine stereoisomers to nicotinic binding sites in rat brain cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Age-related decreases in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET).

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Mapping nicotinic acetylcholine receptors with PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Synthesis and evaluation of 6-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine as a PET tracer for nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Comparative studies of epibatidine derivatives [18F]NFEP and [18F]N-methyl-NFEP: kinetics, nicotine effect, and toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Occupancy of brain nicotinic acetylcholine receptors by nicotine doses equivalent to those obtained when smoking a cigarette

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

External imaging of cerebral muscarinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

(S)- and (R)-[11C]nicotine and the metabolite (R/S)-[11C]cotinine. Preparation, metabolite studies and in vivo distribution in the human brain using PET

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Impairment of neocortical metabolism predicts progression in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Pharmacological evaluation of [11C]A-84543: an enantioselective ligand for in vivo studies of neuronal nicotinic acetylcholine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Nicotine enhances the biosynthesis and secretion of transthyretin from the choroid plexus in rats: implications for beta-amyloid formation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Imaging of cholinergic terminals using the radiotracer [18F](+)-4-fluorobenzyltrozamicol: in vitro binding studies and positron emission tomography studies in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Reduced antinociception in mice lacking neuronal nicotinic receptor subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Overlap between acetylcholinesterase-rich and choline acetyltransferase-positive (cholinergic) axons in human cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Nicotine, brain nicotinic receptors, and neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Fluoro-norchloroepibatidine: preclinical assessment of acute toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

[18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Long-term tacrine treatment in three mild Alzheimer patients: effects on nicotinic receptors, cerebral blood flow, glucose metabolism, EEG, and cognitive abilities.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Uptake and regional distribution of (+)-(R)- and (-)-(S)-N-[methyl-11C]-nicotine in the brains of rhesus monkey. An attempt to study nicotinic receptors in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

In vivo imaging of human cerebral acetylcholinesterase.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

The role of emission tomography in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Rat brain acetylcholinesterase visualized with [11C]physostigmine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

In vivo fatty acid incorporation into brain phospholipids in relation to signal transduction and membrane remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

In vivo positron emission tomography studies on the novel nicotinic receptor agonist [11C]MPA compared with [11C]ABT-418 and (S)(-)[11C]nicotine in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Changes in the rCBF images of patients with Alzheimer's disease receiving Donepezil therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

[Cerebral glucose metabolism in presenile dementia of the Alzheimer type--follow-up of therapy with muscarinergic choline agonists]

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

In vivo PET study of cerebral [11C] methyl- tetrahydroaminoacridine distribution and kinetics in healthy human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

The acetylcholine releaser linopirdine increases parietal regional cerebral blood flow in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Imaging endogenous dopamine competition with [11C]raclopride in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Visual form of Alzheimer's disease and its response to anticholinesterase therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia. A controlled study with 123IQNB and single photon emission computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Synthesis and amyloid binding properties of rhenium complexes: preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Quantification of muscarinic cholinergic receptors with [11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Tacrine interacts with an allosteric activator site on alpha 4 beta 2 nAChRs in M10 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains--in vivo assessment using positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901112-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-3223(00)01112-4

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32077087&oldid=2041999939"